Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping
Tài liệu tham khảo
WHO. WHO Director-General's opening remarks at the media briefing on COVID-19. Available at https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid- 19—11-march-2020. Accessed September, 6 2020.
Lu, 2020, An evidence mapping and analysis of registered COVID-19 clinical trials in China, BMC Med, 18, 167, 10.1186/s12916-020-01612-y
Glasziou, 2020, Waste in Covid-19 research, BMJ (Clinical Res Ed), 369, m1847
Wallace, 2012, Making evidence more wanted: a systematic review of facilitators to enhance the uptake of evidence from systematic reviews and meta-analyses, Int J Evid Based Healthcare, 10, 338, 10.1111/j.1744-1609.2012.00288.x
Shamseer, 2015, Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation, BMJ (Clin Res Ed), 350, g7647
Shea, 2017, AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both, BMJ (Clin Res Ed), 358, j4008, 10.1136/bmj.j4008
Anaya, 2019, Evidence mapping and quality assessment of systematic reviews on therapeutic interventions for oral cancer, Cancer Manag Res, 11, 117, 10.2147/CMAR.S186700
Hetrick, 2010, Evidence mapping: illustrating an emerging methodology to improve evidence-based practice in youth mental health, J Eval Clin Pract, 16, 1025, 10.1111/j.1365-2753.2008.01112.x
Ge, 2018, Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study, J Clin Epidemiol, 93, 45, 10.1016/j.jclinepi.2017.10.012
Tian, 2017, The methodological and reporting quality of systematic reviews from China and the USA are similar, J Clin Epidemiol, 85, 50, 10.1016/j.jclinepi.2016.12.004
Xiu-xia, 2015, The reporting characteristics and methodological quality of Cochrane reviews about health policy research, Health Policy, 119, 503, 10.1016/j.healthpol.2014.09.002
Yao, 2016, The quality of evidence in Chinese meta-analyses needs to be improved, J Clin Epidemiol, 74, 73, 10.1016/j.jclinepi.2016.01.003
Delgado-Rodríguez, 2018, Systematic review and meta-analysis, Med. intensiva, 42, 444, 10.1016/j.medin.2017.10.003
Lu, 2019, Trends in shared decision-making studies from 2009 to 2018: a bibliometric analysis, Front Public Health., 7, 384, 10.3389/fpubh.2019.00384
Wiersinga, 2020, Pathophysiology transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review, JAMA, 324, 782, 10.1001/jama.2020.12839
Yu, 2020, Assessment of the quality of systematic reviews on COVID-19: a comparative study of previous coronavirus outbreaks, J Med Virol, 92, 883, 10.1002/jmv.25901
Bragge, 2011, The global evidence mapping initiative: scoping research in broad topic areas, BMC Med Res Methodol, 11, 92, 10.1186/1471-2288-11-92
Welch, 2019, PROTOCOL: health, social care and technological interventions to improve functional ability of older adults: evidence and gap map, Campbell Syst Rev, 15, e1054, 10.1002/cl2.1054
Li, 2020, Generation and reporting of evidence mapping, Chin J Evid Based Med, 20, 1098
Yang, 2018, Evidence-based social science: the origin, development and prospects, Library Inf, 1
Yang, 2018
Ballesteros, 2017, Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST), BMC Med Res Methodol, 17, 135, 10.1186/s12874-017-0402-9
Miake-Lye, 2019, Massage for pain: an evidence map, J Altern Complement Med (New York, NY), 25, 475, 10.1089/acm.2018.0282
Liu, 2020, Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARSCoV-2 and other acute viral infections: a systematic review and meta-analysis, Cmaj, 192, E734, 10.1503/cmaj.200647
Pang, 2020, Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review, J Clin Med, 9, 33, 10.3390/jcm9030623
Zhong, 2020, Efficacy and safety of current therapeutic options for COVID-19—lessons to be learnt from SARS and MERS epidemic: a systematic review and meta-analysis, Pharmacol Res, 157, 10.1016/j.phrs.2020.104872
Yousefifard, 2020, Antiviral therapy in management of COVID-19: a systematic review on current evidence, Arch Acad Emerg Med, 8, e45
Bhagavathula, 2020, Vaccines and drug therapeutics to lock down novel coronavirus disease 2019 (COVID-19): a systematic review of clinical trials, Cureus., 12, e8342
Ang, 2020, Herbal medicine for the treatment of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of randomized controlled trials, J Clin Med, 9, 1583, 10.3390/jcm9051583
Liu, 2020, Efficacy and safety of integrated traditional Chinese and Western medicine for corona virus disease 2019 (COVID-19): a systematic review and meta-analysis, Pharmacol Res, 158, 10.1016/j.phrs.2020.104896
Gao, 2020, The curative effect on treating COVID-19 by integrated medicine: a systematic review, J Shaanxi Univ Chin Med, 44, 1
Liu, 2020, A meta-analysis of the clinical efficacy of Chinese patent medicine alone or combined with Western medicine in the treatment of COVID-19, Chin Traditional Patent Med, 42, 12
Wu, 2020, Clinical effects of integrated treatnent of traditional Chinese and western medicine on COVID-19: a systematic review, Shanghai J Traditional Chin Med, 54, 29
Sanna, 2020, Children’s heart and COVID-19: up-to-date evidence in the form of a systematic review, Eur J Pediatr, 179, 1
Ge, 2018, Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study, J Clin Epidemiol, 93, 45, 10.1016/j.jclinepi.2017.10.012